ISDA

Entry Detail

PDB ID:

2WF3

Keywords:

Title:

Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-(phenylmethyl)propyl)-1-methyl-1, 3,4,5-tetrahydro-2,1-benzothiazepine-8-carboxamide 2,2-dioxide

Biological Source:

Source Organism:

HOMO SAPIENS

Host Organism:

CRICETULUS GRISEUS

PDB Version:

Deposition Date:

2009-04-02

Release Date:

2009-05-19

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.08 Å

R-Value Free:

0.21

R-Value Work:

0.16

R-Value Observed:

0.16

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:BETA-SECRETASE 1
Mutations:YES
Chain IDs:A
Chain Length:392
Number of Molecules:1
Biological Source:HOMO SAPIENS

UniProt ID:P56817 Pfam ID:PF00026 EC:3.4.23.46

Ligand Molecules

GOL

ZY3

Primary Citation

Second Generation of Bace-1 Inhibitors Part 2: Optimisation of the Non-Prime Side Substituent.

Charrier, N, Clarke, B, Demont, E, Dingwall, C, Dunsdon, R, Hawkins, J, Hubbard, J, Hussain, I, Maile, G, Matico, R, Mosley, J, Naylor, A, O'Brien, A, Redshaw, S, Rowland, P, Soleil, V, Smith, K.J, Sweitzer, S, Theobald, P, Vesey, D, Walter, D.S, Wayne, G.Show

Bioorg.Med.Chem.Lett. 19 3669 ? (2009)

PMID: 19477642 DOI: 10.1016/J.BMCL.2009.03.150

Abstact

Our first generation of hydroxyethylamine transition-state mimetic BACE-1 inhibitors allowed us to validate BACE-1 as a key target for Alzheimer's disease by demonstrating amyloid lowering in an animal model, albeit at rather high doses. Finding a molecule from this series which was active at lower oral doses proved elusive and demonstrated the need to find a novel series of inhibitors with improved pharmacokinetics. This Letter describes the discovery of such inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures